L-DOPA-Coated Manganese Oxide Nanoparticles as Dual MRI Contrast Agents and Drug-Delivery Vehicles
Peer reviewed, Journal article
MetadataShow full item record
Original versionSmall. 2016, 12 (3), 301-306. 10.1002/smll.201502545
Manganese oxide nanoparticles (MONPs) are capable of time‐dependent magnetic resonance imaging contrast switching as well as releasing a surface‐bound drug. MONPs give T2/T2* contrast, but dissolve and release T1‐active Mn2+ and L‐3,4‐dihydroxyphenylalanine. Complementary images are acquired with a single contrast agent, and applications toward Parkinson's disease are suggested.